Sep 6, 2025, 14:04
Chokri Ben Lamine – VTE Prophylaxis in Pregnancy (ASH 2018 Guidelines)
Dr. Chokri Ben Lamine, Adult Hematology and Stem Cell Transplantation Assistant Consultant at Oncology Center of Excellence at King Faisal Specialist Hospital and Research Center, shared an insightful post on X:
“ASH 2018 VTE Prophylaxis in Pregnancy
Prior VTE
- Unprovoked / hormone-related → Antepartum: Yes, Postpartum: Yes
- Provoked (transient risk only) → Antepartum: No, Postpartum: Yes
Thrombophilia
Heterozygous FVL / Prothrombin G20210A
- No FHx → Antepartum: No, Postpartum: No
- +FHx → Antepartum: No, Postpartum: Yes
Protein C deficiency
- No FHx → Antepartum: No, Postpartum: No
- +FHx → Antepartum: No, Postpartum: Yes
Protein S deficiency
- No FHx → Antepartum: No, Postpartum: No
- +FHx → Antepartum: No, Postpartum: Yes
Compound heterozygosity
- No FHx → Antepartum: No, Postpartum: Yes
- +FHx → Antepartum: Yes, Postpartum: Yes
Homozygous FVL
- No FHx → Antepartum: No, Postpartum: Yes
- +FHx → Antepartum: Yes, Postpartum: Yes
Homozgous Prothrombin
- No FHx → Antepartum: No, Postpartum: No
- +FHx → Panel unable to recommend, Postpartum: Yes
Antithrombin deficiency
- No FHx → Antepartum: No, Postpartum: No
- +FHx → Antepartum: No, Postpartum: Yes
Other risks
- No or 1 risk factor → Antepartum: No, Postpartum: Yes
- Assisted reproduction →
-Without ovarian hyperstimulation / high-risk → Antepartum: No
-With OHSS or high-risk thrombophilia → Antepartum: Yes, Postpartum: Yes
Pearls for exams
- Postpartum period = highest risk → most recommendations support prophylaxis here
- Antepartum prophylaxis reserved for high-risk thrombophilia with FHx or prior unprovoked/hormonal VTE
- LMWH = preferred agent
Reference: ASH-SAP 9th Ed, Table 3-2”

More series on VTE featured in Hemostasis Today.
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion
-
Sep 16, 2026, 13:21Sophia Delicou: Mediterranean Network for Haemoglobinopathies and Regional Collaboration
-
Sep 16, 2026, 13:11New Clinical Guidelines for Iron Deficiency from ASH